Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $2.14 billion. The enterprise value is $1.46 billion.
| Market Cap | 2.14B |
| Enterprise Value | 1.46B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 96.48 million shares outstanding. The number of shares has increased by 8.81% in one year.
| Shares Outstanding | 96.48M |
| Shares Change (YoY) | +8.81% |
| Shares Change (QoQ) | +5.56% |
| Owned by Insiders (%) | 1.26% |
| Owned by Institutions (%) | 93.39% |
| Float | 95.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.62 |
| Forward PS | 37.53 |
| PB Ratio | 2.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.03, with a Debt / Equity ratio of 0.11.
| Current Ratio | 9.03 |
| Quick Ratio | 8.45 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.90% and return on invested capital (ROIC) is -45.10%.
| Return on Equity (ROE) | -45.90% |
| Return on Assets (ROA) | -37.90% |
| Return on Capital (ROIC) | -45.10% |
| Revenue Per Employee | $100,008 |
| Profits Per Employee | -$923,008 |
| Employee Count | 526 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.59% in the last 52 weeks. The beta is 1.83, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | -45.59% |
| 50-Day Moving Average | 23.66 |
| 200-Day Moving Average | 27.07 |
| Relative Strength Index (RSI) | 39.55 |
| Average Volume (20 Days) | 1,934,073 |
Short Selling Information
The latest short interest is 13.74 million, so 14.24% of the outstanding shares have been sold short.
| Short Interest | 13.74M |
| Short Previous Month | 14.70M |
| Short % of Shares Out | 14.24% |
| Short % of Float | 14.42% |
| Short Ratio (days to cover) | 8.23 |
Income Statement
In the last 12 months, NTLA had revenue of $52.60 million and -$485.50 million in losses. Loss per share was -$5.36.
| Revenue | 52.60M |
| Gross Profit | 52.60M |
| Operating Income | -517.34M |
| Pretax Income | -485.50M |
| Net Income | -485.50M |
| EBITDA | -476.06M |
| EBIT | -485.50M |
| Loss Per Share | -$5.36 |
Balance Sheet
The company has $791.29 million in cash and $110.86 million in debt, giving a net cash position of $680.43 million or $7.05 per share.
| Cash & Cash Equivalents | 791.29M |
| Total Debt | 110.86M |
| Net Cash | 680.43M |
| Net Cash Per Share | $7.05 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 10.74 |
| Working Capital | 786.13M |
Cash Flow
In the last 12 months, operating cash flow was -$405.42 million and capital expenditures -$12.66 million, giving a free cash flow of -$418.08 million.
| Operating Cash Flow | -405.42M |
| Capital Expenditures | -12.66M |
| Free Cash Flow | -418.08M |
| FCF Per Share | -$4.38 |
Margins
Gross margin is 100.00%, with operating and profit margins of -983.45% and -922.94%.
| Gross Margin | 100.00% |
| Operating Margin | -983.45% |
| Pretax Margin | -922.94% |
| Profit Margin | -922.94% |
| EBITDA Margin | -905.00% |
| EBIT Margin | -922.94% |
| FCF Margin | -794.77% |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.81% |
| Shareholder Yield | -8.81% |
| Earnings Yield | -22.72% |
| FCF Yield | -19.56% |
Analyst Forecast
The average price target for NTLA is $66.93, which is 202.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $66.93 |
| Price Target Difference | 202.17% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 115.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of 3.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.29 |
| Piotroski F-Score | 2 |